Company / Interest Expense per Share
SAB Biotherapeutics, Inc. Interest Expense per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.06
FY2023
5-year range
$0.01 / $0.06
FY2021-FY2023
Trend
+427.8%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share changed +428% YoY in FY2023, a notable deviation from the 2-year average annual change of +195%.
Based on SEC 10-K filings.
0.06 in FY2023.
Increased from $0.02 to $0.06 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, interest expense per share increased 427.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.31 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.06 | +427.8% |
| FY2022 | $0.01 | -37.2% |
| FY2021 | $0.02 | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026